Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Stock indices matter because they summarize broad market performance, guide diversification, and influence risk assessments for investors.
27,507 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
SpaceX has been a marquee name in tech and defense circles. If spacex down from all-time high, investors should analy...
U.S. stock indexes pushed higher Friday, extending gains as AI leaders and mega-cap tech names drive valuations highe...
President Trump says there is no $300 billion reconstruction fund in the Iran framework, while Gulf states push billi...
Credo Technology stock sits near its 52-week peak as AI infrastructure demand remains robust. Investors are debating ...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Whirlpool’s scale appliance demand is a telling gauge of how households spend on big-ticket upgrades. As the housing ...
AI megacaps have powered the bulk of S&P 500 gains over the past two years. When AI-related stocks are stripped out, ...
Stocks pull back as policy tensions between the White House and the Fed intensify, ending a stretch of optimism and s...
Kick off your weekend with a focused set of 10 Sunday Reads for investors. This practical briefing translates headlin...
A rising concentration in a handful of tech names is signaling a wall street flashing warning for many investors. Thi...
Joe Kent, a former Army Special Forces officer and two-time congressional candidate, quit today from a top counterter...